Mega Lifesciences PCL | Income Statement
Fiscal year is January-December. All values THB Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
7,034
7,730
7,945
8,810
9,597
10,342
Cost of Goods Sold (COGS) incl. D&A
4,113
4,664
4,596
5,181
5,333
5,809
Gross Income
2,920
3,066
3,349
3,629
4,264
4,532
SG&A Expense
2,197
2,432
2,660
2,617
2,909
3,184
EBIT
724
634
689
-
1,356
1,348
Non Operating Income/Expense
62
21
152
58
29
99
Interest Expense
28
17
13
22
26
34
Pretax Income
757
638
828
933
1,301
1,413
Income Tax
133
90
132
138
186
203
Equity in Affiliates
-
-
-
-
2
4
Consolidated Net Income
624
548
696
795
1,113
1,206
Net Income
624
548
696
795
1,113
1,206
Net Income After Extraordinaries
624
548
696
795
1,113
1,206
Net Income Available to Common
624
548
696
795
1,113
1,206
EPS (Basic)
0.84
0.63
0.80
0.92
1.29
1.39
Basic Shares Outstanding
747
865
865
865
865
865
EPS (Diluted)
0.84
0.63
0.80
0.92
1.28
1.39
Diluted Shares Outstanding
747
865
865
868
868
869
EBITDA
823
765
834
1,164
1,508
1,496
Minority Interest Expense
-
-
-
-
-
-
About Mega Lifesciences
View Profile
